This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Jonas Bostrom

Principal scientist, CVMD iMed

Jonas Boström is a Principal Scientist at AstraZeneca in the CVMD iMed. He obtained a M.S. in Chemistry at the University of Gothenburg in 1996 and a Ph.D. in Computational Medicinal Chemistry in 2000 at the Royal Danish School of Pharmacy (Copenhagen, Denmark). After a short spell at H. Lundbeck A/S he joined AstraZeneca. Jonas has gained knowledge of most aspects of preclinical drug discovery from his 15 years in the pharmaceutical industry. Among other things, this has resulted in 15 patent specifications, including 10 candidate drugs. Current research interests include combining new technology, informatics, and science in innovative ways to tackle the challenging tasks in drug discovery, as well as trying to distinguish science facts from science fiction.

You are viewing: All posts Reset filters

Our Other Authors